Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer stem cells: Biology and therapeutic implications.
Butti R, Gunasekaran VP, Kumar TVS, Banerjee P, Kundu GC. Butti R, et al. Among authors: kundu gc. Int J Biochem Cell Biol. 2019 Feb;107:38-52. doi: 10.1016/j.biocel.2018.12.001. Epub 2018 Dec 5. Int J Biochem Cell Biol. 2019. PMID: 30529656 Review.
Osteopontin: role in cell signaling and cancer progression.
Rangaswami H, Bulbule A, Kundu GC. Rangaswami H, et al. Among authors: kundu gc. Trends Cell Biol. 2006 Feb;16(2):79-87. doi: 10.1016/j.tcb.2005.12.005. Epub 2006 Jan 10. Trends Cell Biol. 2006. PMID: 16406521 Review.
Osteopontin: a potentially important therapeutic target in cancer.
Ahmed M, Behera R, Chakraborty G, Jain S, Kumar V, Sharma P, Bulbule A, Kale S, Kumar S, Mishra R, Raja R, Saraswati S, Kaur R, Soundararajan G, Kumar D, Thorat D, Sanyal M, Ramdasi A, Ghosh P, Kundu GC. Ahmed M, et al. Among authors: kundu gc. Expert Opin Ther Targets. 2011 Sep;15(9):1113-26. doi: 10.1517/14728222.2011.594438. Epub 2011 Jul 25. Expert Opin Ther Targets. 2011. PMID: 21718227 Review.
Osteopontin as a therapeutic target for cancer.
Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, Gorain M, Kale S, Kumar D, Kumar S, Totakura KV, Roy G, Sharma P, Shetti D, Soundararajan G, Thorat D, Tomar D, Nalukurthi R, Raja R, Mishra R, Yadav AS, Kundu GC. Bandopadhyay M, et al. Among authors: kundu gc. Expert Opin Ther Targets. 2014 Aug;18(8):883-95. doi: 10.1517/14728222.2014.925447. Epub 2014 Jun 4. Expert Opin Ther Targets. 2014. PMID: 24899149 Review.
MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
Ghosh A, Dasgupta D, Ghosh A, Roychoudhury S, Kumar D, Gorain M, Butti R, Datta S, Agarwal S, Gupta S, Krishna Dhali G, Chowdhury A, Schmittgen TD, Kundu GC, Banerjee S. Ghosh A, et al. Among authors: kundu gc. Cell Death Dis. 2017 Mar 30;8(3):e2706. doi: 10.1038/cddis.2017.123. Cell Death Dis. 2017. PMID: 28358369 Free PMC article.
120 results